Immunity
Volume 55, Issue 6, 14 June 2022, Pages 945-964
Journal home page for Immunity

Perspective
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases

https://doi.org/10.1016/j.immuni.2022.05.004Get rights and content

Summary

Many aspects of SARS-CoV-2 have fully conformed with the principles established by decades of viral immunology research, ultimately leading to the crowning achievement of highly effective COVID-19 vaccines. Nonetheless, the pandemic has also exposed areas where our fundamental knowledge is thinner. Some key unknowns are the duration of humoral immunity post-primary infection or vaccination and how long booster shots confer protection. As a corollary, if protection does not last as long as desired, what are some ways it can be improved? Here, I discuss lessons from other infections and vaccines that point to several key features that influence durable antibody production and the perseverance of immunity. These include (1) the specific innate sensors that are initially triggered, (2) the kinetics of antigen delivery and persistence, (3) the starting B cell receptor (BCR) avidity and antigen valency, and (4) the memory B cell subsets that are recalled by boosters. I further highlight the fundamental B cell-intrinsic and B cell-extrinsic pathways that, if understood better, would provide a rational framework for vaccines to reliably provide durable immunity.

Keywords

antibodies
plasma cells
COVID-19
SARS-CoV-2
vaccines
viruses
durable immunity

Cited by (0)

View Abstract